NHS England has provided £2.8 million worth of medicine for Teddy Shaw
NHS England has provided £2....
Subscribe to Newsletter

NHS England has provided £2.8 million worth of medicine for Teddy Shaw

15 February 2023
2 min.
NHS England has provided £2.8 million worth of medicine for Teddy Shaw

A cure for metachromatic leukodystrophy

The National Health Service, NHS has given a child with metachromatic leukodystrophy a £2.8 million drug free of charge for the first time, The Times has reported.

Metachromatic leukodystrophy is a congenital disease caused by a defect in one of the genes. The body does not produce substances that break down the fatty substance in the brain, causing the organ to be unable to transmit signals to other parts of the body. As a consequence, the children lose their sight, their ability to speak and move, and after 5 to 8 years, they die.

Teddy Shaw, 18 months old, was the first British child to receive this costly medicine at government expense. "We are extremely grateful and thankful that she now has the opportunity to lead a long and normal life," the newspaper quoted the girl's mother as saying.

NHS England chief executive Amanda Pritchard said the breakthrough meant children like Teddy could do things every child should be able to do, "such as go to school and play with friends". People born with a terminal illness can now lead normal, healthy lives, she said.

A 19-month-old baby called Teddy has received life-saving gene therapy treatment for metachromatic leukodystrophy (MLD) a disorder that causes severe damage to the nervous system and organs in NHS first.

The one-time Libmeldy treatment (atidarsagene autotemcel) works by taking a patient's stem cells, replacing the defective gene that causes MLD and then reintroducing the treated cells back into the patient.

It is listed as one of the "most expensive drugs" in the world at a cost of £2.8m; however, NHS England is known to have negotiated a "substantial confidential discount" last year.

Libmeldy is available on the NHS at the Royal Manchester Children's Hospital, one of five European centres carrying out the treatment.

Around five babies with MLD are born each year in England. Those with MLD starting before 30 months old deteriorate quickly and usually die between the ages of five and eight. Those whose condition starts between 30 months and six years old have a life expectancy of 10-20 years longer.

Persons1 and Companies2 in the news

Chief Executive of National Health Service England (NHS England)
1 place
The Times
1 place
Source foto:
Rating companies
18 Mention
12 Mention
Daily Mail
9 Mention
Labour Party
6 Mention
X (Twitter)
6 Mention
Channel 4
6 Mention
The Sun
6 Mention


News GlobalEng.biz -this is the latest and most up-to-date information about the resonant events that have occurred in the region. The task of the resource's news feed is to convey to readers information about important events in business, politics, economics, healthcare, culture and other spheres of life in England with maximum accuracy and objectivity.
News GlobalEng.biz - this is coverage of the economic processes taking place in England, the latest news of public life, incidents and an overview of political events. English news is information about the activities of small and medium-sized businesses, the work of housing and communal services, the implementation of significant projects. The site's journalists describe not only the life of the region, but also talk about the current state of the English economy. Everything you need to know about innovations in the field of industry and agriculture, economy and government is collected in the "News" section on GlobalEng.biz.
News of England promptly informs the reader, shows the real picture and opens up topical topics. Communication with government structures and business gives us the opportunity to provide our readers with reliable, information-rich material.
The main page of the portal contains the key news of England!
Alena Potapova

Development Director
Died this year
Born this year